Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL275224 (beta-carboline, norharman, norharmane) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
acetylcholinesterase (Yt blood group)/Acetylcholinesterase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL220] [GtoPdb: 2465] [UniProtKB: P22303] | ||||||||
ChEMBL | Inhibition of AChE (unknown origin) | B | 4.4 | pIC50 | >40000 | nM | IC50 | J Med Chem (2021) 64: 1392-1422 [PMID:33528252] |
butyrylcholinesterase/Butyrylcholinesterase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1914] [GtoPdb: 2471] [UniProtKB: P06276] | ||||||||
ChEMBL | Inhibition of BuChE (unknown origin) | B | 4.4 | pIC50 | >40000 | nM | IC50 | J Med Chem (2021) 64: 1392-1422 [PMID:33528252] |
casein kinase 2, alpha prime polypeptide subunit/casein kinase 2, beta polypeptide subunit/casein kinase 2, alpha 1 polypeptide subunit/Casein kinase II in Human (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL2095191] [GtoPdb: 1550, 1551, 1549] [UniProtKB: P19784, P67870, P68400] | ||||||||
ChEMBL | Inhibitory activity against CKII kinase. | B | 4.6 | pIC50 | >25000 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 2419-2422 [PMID:12824047] |
Chitinase in Onchocerca volvulus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795119] [UniProtKB: Q25615] | ||||||||
ChEMBL | Inhibition of L3 larval stage of Onchocerca volvulus chitinase using 4-methylumbelliferyl-N-N'-N''-beta-chitotrioside as substrate assessed as release of 4-methylumbelliferone measured for 10 mins by fluorescence assay | B | 5.07 | pIC50 | 8460 | nM | IC50 | ACS Med Chem Lett (2015) 6: 339-343 [PMID:25815157] |
DNA topoisomerase I in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1781] [GtoPdb: 2636] [UniProtKB: P11387] | ||||||||
ChEMBL | Inhibition of Topoisomerase 1 (unknown origin) | B | 4.51 | pIC50 | 31000 | nM | IC50 | Eur J Med Chem (2021) 224: 113688-113688 [PMID:34332400] |
dual specificity tyrosine phosphorylation regulated kinase 1A/Dual-specificity tyrosine-phosphorylation regulated kinase 1A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2292] [GtoPdb: 2009] [UniProtKB: Q13627] | ||||||||
ChEMBL | Inhibition of DYRK1A (unknown origin) | B | 5.74 | pIC50 | >1800 | nM | IC50 | J Med Chem (2021) 64: 1392-1422 [PMID:33528252] |
GABAA receptor π subunit/GABAA receptor δ subunit/GABAA receptor α1 subunit/GABAA receptor β1 subunit/GABAA receptor γ2 subunit/GABAA receptor β3 subunit/GABAA receptor α5 subunit/GABAA receptor α3 subunit/GABAA receptor α2 subunit/GABAA receptor β2 subunit/GABAA receptor α4 subunit/GABAA receptor ε subunit/GABAA receptor α6 subunit/GABAA receptor γ1 subunit/GABAA receptor γ3 subunit/GABAA receptor θ subunit/GABA-A receptor; anion channel in Human (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL2093872] [GtoPdb: 419, 416, 404, 410, 414, 412, 408, 406, 405, 411, 407, 417, 409, 413, 415, 418] [UniProtKB: O00591, O14764, P14867, P18505, P18507, P28472, P31644, P34903, P47869, P47870, P48169, P78334, Q16445, Q8N1C3, Q99928, Q9UN88] | ||||||||
ChEMBL | Inhibition on Benzodiazepine receptor | B | 5.79 | pIC50 | 1621.81 | nM | IC50 | J Med Chem (1997) 40: 4360-4371 [PMID:9435905] |
ChEMBL | Displacement of [3H]flunitrazepam from GABAA (unknown origin ) receptor by radioligand binding assay | B | 5.8 | pIC50 | 1600 | nM | IC50 | J Med Chem (2021) 64: 1392-1422 [PMID:33528252] |
GABAA receptor π subunit/GABAA receptor β1 subunit/GABAA receptor δ subunit/GABAA receptor γ2 subunit/GABAA receptor α5 subunit/GABAA receptor α3 subunit/GABAA receptor γ1 subunit/GABAA receptor α2 subunit/GABAA receptor α4 subunit/GABAA receptor γ3 subunit/GABAA receptor α6 subunit/GABAA receptor α1 subunit/GABAA receptor β3 subunit/GABAA receptor β2 subunit/GABAA receptor ε subunit/GABA-A receptor; anion channel in Rat (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL1907607] [GtoPdb: 419, 410, 416, 414, 408, 406, 413, 405, 407, 415, 409, 404, 412, 411, 417] [UniProtKB: O09028, P15431, P18506, P18508, P19969, P20236, P23574, P23576, P28471, P28473, P30191, P62813, P63079, P63138, Q91ZM7, Q9ES14] | ||||||||
ChEMBL | In vitro inhibition of [3H]diazepam binding to benzodiazepine receptor in rat cerebral cortical membrane | B | 5.79 | pKi | 1620 | nM | Ki | J Med Chem (1982) 25: 1081-1091 [PMID:6127411] |
ChEMBL | Binding affinity for rat benzodiazepine receptor inverse agonist site | B | 5.79 | pIC50 | 1621.81 | nM | IC50 | J Med Chem (1996) 39: 2129-2140 [PMID:8667357] |
ChEMBL | Binding affinity towards benzodiazepine receptor inverse agonist site by the displacement of [3H]diazepam in rat cerebral cortical membranes. | B | 5.79 | pIC50 | 1621.81 | nM | IC50 | J Med Chem (1993) 36: 2929-2937 [PMID:8411009] |
ChEMBL | In vitro inhibition of binding to the benzodiazepine receptor in rat cerebral cortical membrane using [3H]diazepam as radioligand | B | 5.79 | pIC50 | 1620 | nM | IC50 | J Med Chem (1988) 31: 1854-1861 [PMID:2842507] |
ChEMBL | In vitro inhibition of 3[H]Diazepam binding to Benzodiazepine receptor from rat cerebral cortical membranes | B | 5.79 | pIC50 | 1620 | nM | IC50 | J Med Chem (1990) 33: 2343-2357 [PMID:2167977] |
indoleamine 2,3-dioxygenase 1/Indoleamine 2,3-dioxygenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4685] [GtoPdb: 2829] [UniProtKB: P14902] | ||||||||
GtoPdb | - | - | 0.92 | pKi | 120000000 | nM | Ki | Bioorg Med Chem (2011) 19: 1550-61 [PMID:21269836] |
ChEMBL | Inhibition of IDO | B | 6.92 | pKi | 120 | nM | Ki | Bioorg Med Chem (2011) 19: 1550-1561 [PMID:21269836] |
ChEMBL | Inhibition of His-tagged recombinant human IDO1 expressed in Escherichia coli using tryptophan as substrate by spectrophotometric analysis | B | 4.05 | pIC50 | 90000 | nM | IC50 | Bioorg Med Chem (2012) 20: 1354-1363 [PMID:22112538] |
component of inhibitor of nuclear factor kappa B kinase complex/Inhibitor of nuclear factor kappa B kinase alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3476] [GtoPdb: 1989] [UniProtKB: O15111] | ||||||||
ChEMBL | Inhibitory activity against IkappaB kinase(IKK) isolated from HeLa cells activated with recombinant MEEK1 in an ELISA phosphorylation assay. | B | 4.82 | pIC50 | 15000 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 2419-2422 [PMID:12824047] |
Monoamine oxidase A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1951] [GtoPdb: 2489] [UniProtKB: P21397] | ||||||||
ChEMBL | Competitive inhibition of recombinant human MAO-A using kynuramine as substrate by Lineweaver-Burk plot analysis | B | 6.59 | pKi | 260 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2403-2407 [PMID:29925480] |
Monoamine oxidase B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2039] [GtoPdb: 2490] [UniProtKB: P27338] | ||||||||
ChEMBL | Reversible inhibition of MAO-B | B | 5.92 | pKi | 1200 | nM | Ki | Bioorg Med Chem (2011) 19: 7416-7424 [PMID:22071524] |
ChEMBL | Competitive inhibition of recombinant human MAO-B expressed in baculovirus system using kynuramine as substrate after 40 mins by Lineweaver-Burk plot analysis | B | 5.95 | pKi | 1120 | nM | Ki | Bioorg Med Chem Lett (2016) 26: 4714-4719 [PMID:27575476] |
tryptophan 2,3-dioxygenase/Tryptophan 2,3-dioxygenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2140] [GtoPdb: 2887] [UniProtKB: P48775] | ||||||||
ChEMBL | Inhibition of TDO (unknown origin) assessed as reduction in N-formylkynurenine formation using L-tryptophan as substrate incubated for 75 mins by UV absorbance based analysis | B | 5.92 | pIC50 | 1200 | nM | IC50 | J Med Chem (2022) 65: 11214-11228 [PMID:35938398] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]